Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

I think we have left out a very important componen

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36564
(Total Views: 310)
Posted On: 05/20/2021 2:09:38 PM
Posted By: Buildit
I think we have left out a very important component of the conversation so far on the Class A/B discussion.

The IPO is for ~5.5-6.3MM shares. If DJ takes their option for extra shares and BOTH sets of warrants are exercised, that may yield a whopping total of ~20MM shares.

If we presume there is interest in NGIO, that is an absurdly low amount of shares.

For discussion purposes, I’ll make some assumptions and exaggerations here...

Let’s look at a worst case for the Class A shares and say the market initially chooses to ignore them. If the value of NGIO is perceived to be $500MM, these 20MM shares would, in theory, trade for $25/sh.

Now any intelligent person who looks at this scenario is going to say, “Wait a second! These Class A shares are trading on OTC for $X/sh (presumably way below that $25/sh).” A quick look, and they can see the risk of Class A vs Class B:

1). Class A is behind Class B’s $11/share redemption if we go bankrupt.

2). The conversion rate of shares.

3). Naz vs OTC.

They can also do some research and see that the controlling company that holds the voting rights and its CEO also hold shares of Class A. This isn’t some abandoned class that is going to be hung out to dry. So this can be seen as mitigating factors to these risks.

Meanwhile, the investors who bought at $25 say, “Holy crap! Look at all these other shares out here that actually control the voting (directly or indirectly w the super voting shares)” and realize they can take on some additional/reasonable risk and own vastly more shares.

People start to realize there is an arbitrage opportunity, and the gap between the share prices starts to close.

The smaller that gap gets, the smaller the conversion risk becomes, and maybe we have a self-fulfilling move to $4+ on the Class A shares, and we convert.

As Balleroni so astutely stated, maybe this is a master stroke by Joe to sabotage the saboteurs. It seems to be a creative maneuver against a nefarious move. And if it saves the whole deal from purgatory or failure, it will be worth seeing this through to the conversion.


(7)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us